TTY Biopharm Co Ltd (4105) — Cash Flow Reinvestment Rate
TTY Biopharm Co Ltd (4105) has a Cash Flow Reinvestment Rate of 0.27x as of March 2026, reinvesting NT$178.28 Million (capex NT$128.28 Million plus investments NT$-50.00 Million) from operating cash flow of NT$654.16 Million. See 4105 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
TTY Biopharm Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for TTY Biopharm Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 4105 cash flow metrics.
Annual Cash Flow Reinvestment Rate for TTY Biopharm Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for TTY Biopharm Co Ltd. See 4105 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$323.19 Million | NT$1.76 Billion | NT$150.83 Million | ▼ -5.7% |
| 2024 | 0.19x | NT$262.47 Million | NT$1.35 Billion | NT$134.29 Million | ▲ +106.5% |
| 2023 | 0.09x | NT$102.21 Million | NT$1.09 Billion | NT$99.58 Million | ▼ -31.6% |
| 2022 | 0.14x | NT$170.18 Million | NT$1.24 Billion | NT$135.50 Million | ▲ +96.1% |
| 2021 | 0.07x | NT$88.25 Million | NT$1.26 Billion | NT$74.15 Million | ▼ -92.5% |
| 2020 | 0.93x | NT$490.68 Million | NT$526.35 Million | NT$181.86 Million | ▲ +306.0% |
| 2019 | 0.23x | NT$277.82 Million | NT$1.21 Billion | NT$69.86 Million | ▼ -86.7% |
| 2018 | 1.73x | NT$1.86 Billion | NT$1.07 Billion | NT$74.09 Million | ▲ +155.8% |
| 2017 | 0.68x | NT$675.00 Million | NT$996.52 Million | NT$96.79 Million | — |